By Hidden Values Daily 
Following recent challenges, these drugmakers could see solid clinical progress in the next 12 to 18 months. Both could launch products with significant sales potential and ride that wave through the medium term.
Source: https://www.fool.com/investing/2026/01/27/2-biotech-stocks-s…